News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER at mid-year: 2026 progress and what’s ahead
In 2026 so far, RECOVER has published new research findings across nearly all its different studies and will soon be enrolling participants for the next phases of the adult observational study and clinical trials.
Feature
173 Results
173 Results
RECOVER-NEURO enrolls first participant in trial
RECOVER-NEURO will enroll 315 people and test several different treatments for Long COVID patients who have difficulty focusing, thinking clearly, and remembering things.
News Release
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment
Initially, RECOVER will test at least four potential treatments for Long COVID, with test of seven more treatments expected in the coming months.
News Release
RECOVER-VITAL enrolls first participant in trial
RECOVER-VITAL will enroll 900 people over the next six months and seek to understand whether taking Paxlovid, an antiviral drug, can improve Long COVID symptoms caused by viral persistence.
News Release
R3 Seminar Recap: RECOVER in Action: Disparities and Environmental Risk Factors in PASC, EHR Insights
During the July 11th RECOVER Research Review (R3) Seminar, presenters discussed the disparities and environmental risk factors in PASC using EHR Insights. This seminar explored racial and ethnic disparities as well as community-level environmental factors in PASC among adults.
R3 Seminar Recap
R3 Seminar Recap: RECOVER in Action: Characterization of PASC Among Adults, Cohort Insights
During the June 13th RECOVER Research Review (R3) Seminar, RECOVER researchers described a symptom-based approach for defining long COVID in adults from a study published in JAMA. This presentation is based upon some early findings from the RECOVER Adult Observational Cohort study.
R3 Seminar Recap
RECOVER Research Q&A: RECOVER “First Look” Adult Cohort Study
Find answers to some of the most frequently asked questions (FAQs) about the first findings from RECOVER's research on Long COVID in adults.
Q&A
Large study provides scientists with deeper insight into Long COVID symptoms
RECOVER researchers have identified the 12 symptoms that are most likely to be experienced by adults with Long COVID.
News Release
Obstructive sleep apnea associated with increased risks for Long COVID
RECOVER researchers examined more than 2.2 million Americans' health data to learn why some people are more likely to develop Long COVID.
News Release